PET/CT with 18-FDG
Sponsors
University of Pennsylvania, NHS Greater Glasgow and Clyde, Insel Gruppe AG, University Hospital Bern, Kresten Krarup Keller, Fatma Abelzaher Mahmoud Ahmed
Conditions
Atherosclerotic DiseaseCancerCancer Patients Referred to do PET/CT StudyCardiotoxicityConservative Treatment TherapyDementia, Lewy BodyParkinson DiseasePolymyalgia Rheumatica (PMR)
Phase 2
Unknown Phase
BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS
Active, not recruitingNCT06597045
Start: 2022-08-30End: 2024-11-20Target: 60Updated: 2024-09-19
Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder
RecruitingNCT06629207
Start: 2024-10-07End: 2026-08-01Target: 20Updated: 2024-11-08
Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia Rheumatica
RecruitingNCT07010484
Start: 2025-08-21End: 2032-08-31Target: 149Updated: 2025-10-01
Volumetric Parameter of 18F-FDG PET/CT in Characterizing Thyroid Incidentalomas
Not yet recruitingNCT07163806
Start: 2025-10-30End: 2028-05-30Target: 88Updated: 2025-09-29
Comparative Analysis of SUV Measurements Using Different Correction Methods in Oncological PET/CT Imaging.
Not yet recruitingNCT07306975
Start: 2025-12-10End: 2027-12-01Target: 80Updated: 2025-12-29